Sernova Corp. (TSE:SVA – Get Free Report)’s stock price traded down 4.5% on Friday . The company traded as low as C$0.21 and last traded at C$0.21. 56,087 shares were traded during mid-day trading, a decline of 64% from the average session volume of 157,444 shares. The stock had previously closed at C$0.22.
Sernova Price Performance
The company has a debt-to-equity ratio of 16.55, a quick ratio of 18.11 and a current ratio of 0.32. The stock has a market cap of C$68.32 million, a PE ratio of -1.62 and a beta of 1.35. The stock has a 50 day moving average of C$0.23 and a two-hundred day moving average of C$0.25.
About Sernova
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Featured Stories
- Five stocks we like better than Sernova
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- What Are Dividends? Buy the Best Dividend Stocks
- Oilfield Leader SLB: An AI Name You Need to Know
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
